Clik here to view.
Diabetes: Glooko links up with Wal-Mart | Wall Street Beat
Glooko and Wal-Mart (NYSE:WMT) are in cahoots over diabetes monitoring, with a deal that connects Glooko’s app, 2 of the superstore’s blood glucose meters and Apple‘s (NSDQ:AAPL) iPhone. It’s part of...
View ArticleClik here to view.
NeuroMetrix slides on 3Q results
NeuroMetrix (NSDQ:NURO) reported another consecutive quarter at a net loss, spurring a 9.1% drop on Wall Street yesterday, where shares closed at 50¢. The Waltham, Mass.-based medical device maker...
View ArticleClik here to view.
iCad soars on Medicare reimbursement nod | Wall Street Beat
iCad (NSDQ:ICAD) shares nearly doubled their value on Wall Street today after the medical device company said the Centers for Medicare & Medicaid approved a big increase in the reimbursement rate...
View ArticleClik here to view.
NeuroMetrix lands FDA OK for Sensus pain management system
NeuroMetrix (NSDQ:NURO) landed FDA clearance for its Sensus pain management system, a non-invasive transcutaneous electrical nerve stimulator designed to relieve the symptoms of diabetic neuropathy....
View ArticleClik here to view.
Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat
Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from...
View ArticleClik here to view.
Delcath to pare 20% of its U.S. workforce | Personnel Moves
Queensbury, N.Y.-based Delcath (NSDQ:DCTH) announced last week that it plans to pare its workforce by about 20%, the latest in a series of layoff announcements from the oncology devices maker. This is...
View ArticleClik here to view.
FDA green-lights NeuroMetrix pain treatment device for bed-time use
NeuroMetrix’s (NSDQ:NURO) Sensus wearable pain management device can now be paired with pajamas thanks to the FDA’s clearance of the device for use during sleep. The FDA typically requires warning...
View ArticleClik here to view.
NeuroMetrix falls despite narrowed Q3 losses
NeuroMetrix (NSDQ:NURO) shares lost more than 4% of their value yesterday after the medical device company reported a more than 25% sales slide during the 3rd quarter. Despite the top-line slide,...
View ArticleClik here to view.
Diabetes: NeuroMetrix gains on Chinese distribution deal
NeuroMetrix (NSDQ:NURO) said it inked a deal with Omron Medical Devices, a subsidiary of Omron Healthcare China, for the distribution rights to NeuroMetrix’s NC-stat DPNCheck in China. The NC-stat DPN...
View ArticleClik here to view.
NeuroMetrix signs distribution deal with DJO Global
NeuroMetrix (NSDQ:NURO) said it signed a national distribution deal with DJO Global for its Sensus pain management system. The Sensus system is a non-invasive transcutaneous electrical nerve...
View ArticleClik here to view.
What medtech companies is BlackRock buying into?
BlackRock Inc. (NYSE:BLK) boosted its stake in several medical device companies, including a triple-digit increase for its investment in Biolase (NSDQ:BIOL), but cut its holdings in other medtech...
View ArticleClik here to view.
NeuroMetrix soars on Japanese market approval of diabetes test
NeuroMetrix (NSDQ:NURO) got a major Wall Street boost today after announcing Japanese market approval for its NC-stat DPNCheck test for diabetic peripheral neuropathy. The NC-stat DPNCheck is an early...
View ArticleClik here to view.
Press Release: NeuroMetrix receives marketing certification in Japan for...
WALTHAM, Mass.–NeuroMetrix, Inc. (NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve...
View ArticleClik here to view.
Volcano’s commercial sales prez bows out | Personnel Moves
Volcano (NSDQ:VOLC) said last week that its president for U.S. & APLAC commercial sales, Jorge (George) Quinoy, is leaving the company effective today. Volcano said it agreed to pay Quinoy a...
View ArticleClik here to view.
NeuroMetrix wins FDA nod for over-the-counter chronic pain device
NeuroMetrix (NSDQ:NURO) said today that the FDA granted 510(k) clearance for over-the-counter sales of its wearable chronic pain device based on its Sensus pain management system. The clearance allows...
View ArticleClik here to view.
NeuroMetrix names new consumer GM | Personnel Moves
NeuroMetrix (NSDQ:NURO) tapped a veteran of the consumer businesses at Philips (NYSE:PHG) and Johnson & Johnson (NYSE:JNJ) to be its new senior vice president and general manager for its own...
View ArticleClik here to view.
Year in review: CEOs chime in on 2014
As 2014 draws to a close, MassDevice.com asked several medical device company CEOs for their takes on 2014 and what they’re looking for in 2015. We wanted to get their views on the major trends seen...
View ArticleClik here to view.
NeuroMetrix raises $14.7m
NeuroMetrix (NSDQ:NURO) said last week that it raised $14.7 million in its most recent funding round. Waltham, Mass.-based NeuroMetrix said it sold 147,000 shares at $100 per share and repurchased all...
View ArticleClik here to view.
NeuroMetrix inks distro deal with Advantage Consumer Healthcare
NeuroMetrix (NSDQ:NURO) said yesterday it signed a deal with supply chain company Advantage Consumer Healthcare to expand the distribution of its Quell wearable pain relief device. The new deal will...
View ArticleClik here to view.
NeuroMetrix touts Quell study data
NeuroMetrix (NSDQ:NURO) released preliminary data on Tuesday from a clinical study of its Quell wearable pain relief device for patients with chronic pain. The study found that 81% of the patients...
View Article
